Literature DB >> 23744766

Endurance training improves insulin sensitivity and body composition in prostate cancer patients treated with androgen deprivation therapy.

Thine Hvid1, Kamilla Winding, Anders Rinnov, Thomas Dejgaard, Carsten Thomsen, Peter Iversen, Klaus Brasso, Kari J Mikines, Gerrit van Hall, Birgitte Lindegaard, Thomas P J Solomon, Bente K Pedersen.   

Abstract

Insulin resistance and changes in body composition are side effects of androgen deprivation therapy (ADT) given to prostate cancer patients. The present study investigated whether endurance training improves insulin sensitivity and body composition in ADT-treated prostate cancer patients. Nine men undergoing ADT for prostate cancer and ten healthy men with normal testosterone levels underwent 12 weeks of endurance training. Primary endpoints were insulin sensitivity (euglycemic-hyperinsulinemic clamps with concomitant glucose-tracer infusion) and body composition (dual-energy X-ray absorptiometry and magnetic resonance imaging). The secondary endpoint was systemic inflammation. Statistical analysis was carried out using two-way ANOVA. Endurance training increased VO2max (ml(O2)/min per kg) by 11 and 13% in the patients and controls respectively (P<0.0001). The patients and controls demonstrated an increase in peripheral tissue insulin sensitivity of 14 and 11% respectively (P<0.05), with no effect on hepatic insulin sensitivity (P=0.32). Muscle protein content of GLUT4 (SLC2A4) and total AKT (AKT1) was also increased in response to the training (P<0.05 and P<0.01 respectively). Body weight (P<0.0001) and whole-body fat mass (FM) (P<0.01) were reduced, while lean body mass (P=0.99) was unchanged. Additionally, reductions were observed in abdominal (P<0.01), subcutaneous (P<0.05), and visceral (P<0.01) FM amounts. The concentrations of plasma markers of systemic inflammation were unchanged in response to the training. No group × time interactions were observed, except for thigh intermuscular adipose tissue (IMAT) (P=0.01), reflecting a significant reduction in the amount of IMAT in the controls (P<0.05) not observed in the patients (P=0.64). In response to endurance training, ADT-treated prostate cancer patients exhibited improved insulin sensitivity and body composition to a similar degree as eugonadal men.

Entities:  

Keywords:  androgen deprivation therapy; endurance training; insulin sensitivity and body composition; prostate cancer

Mesh:

Substances:

Year:  2013        PMID: 23744766     DOI: 10.1530/ERC-12-0393

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  15 in total

Review 1.  The effects of resistance exercise on physical performance and health-related quality of life in prostate cancer patients: a systematic review.

Authors:  T Hasenoehrl; M Keilani; T Sedghi Komanadj; M Mickel; M Margreiter; M Marhold; R Crevenna
Journal:  Support Care Cancer       Date:  2015-05-24       Impact factor: 3.603

Review 2.  Why exercise has a crucial role in cancer prevention, risk reduction and improved outcomes.

Authors:  Robert Thomas; Stacey A Kenfield; Yuuki Yanagisawa; Robert U Newton
Journal:  Br Med Bull       Date:  2021-09-10       Impact factor: 5.841

Review 3.  The effect of exercise training on cardiometabolic health in men with prostate cancer receiving androgen deprivation therapy: a systematic review and meta-analysis.

Authors:  Ashley Bigaran; Eva Zopf; Jason Gardner; Andre La Gerche; Declan G Murphy; Erin J Howden; Michael K Baker; Prue Cormie
Journal:  Prostate Cancer Prostatic Dis       Date:  2020-08-28       Impact factor: 5.554

Review 4.  The use of exercise interventions to overcome adverse effects of androgen deprivation therapy.

Authors:  Peter Busch Østergren; Caroline Kistorp; Finn Noe Bennedbæk; Jens Faber; Jens Sønksen; Mikkel Fode
Journal:  Nat Rev Urol       Date:  2016-04-26       Impact factor: 14.432

Review 5.  Skeletal Muscle-Adipose Tissue-Tumor Axis: Molecular Mechanisms Linking Exercise Training in Prostate Cancer.

Authors:  Sílvia Rocha-Rodrigues; Andreia Matos; José Afonso; Miguel Mendes-Ferreira; Eduardo Abade; Eduardo Teixeira; Bruno Silva; Eugenia Murawska-Ciałowicz; Maria José Oliveira; Ricardo Ribeiro
Journal:  Int J Mol Sci       Date:  2021-04-25       Impact factor: 5.923

6.  A pilot randomised controlled trial of a periodised resistance training and protein supplementation intervention in prostate cancer survivors on androgen deprivation therapy.

Authors:  Jacqueline L Kiwata; Tanya B Dorff; E Todd Schroeder; George J Salem; Christianne J Lane; Judd C Rice; Mitchell E Gross; Christina M Dieli-Conwright
Journal:  BMJ Open       Date:  2017-07-10       Impact factor: 2.692

Review 7.  Exercise-induced biochemical changes and their potential influence on cancer: a scientific review.

Authors:  Robert James Thomas; Stacey A Kenfield; Alfonso Jimenez
Journal:  Br J Sports Med       Date:  2016-12-19       Impact factor: 13.800

8.  Muscle specific miRNAs are induced by testosterone and independently upregulated by age.

Authors:  Søren Nielsen; Thine Hvid; Meghan Kelly; Birgitte Lindegaard; Christine Dethlefsen; Kamilla Winding; Neha Mathur; Camilla Scheele; Bente K Pedersen; Matthew J Laye
Journal:  Front Physiol       Date:  2014-01-23       Impact factor: 4.566

Review 9.  A review of clinical effects associated with metabolic syndrome and exercise in prostate cancer patients.

Authors:  J L Kiwata; T B Dorff; E T Schroeder; M E Gross; C M Dieli-Conwright
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-06-28       Impact factor: 5.554

10.  Effects of a six-month supervised physical exercise program on physical and cardio-metabolic profile and quality of life in patients with prostate cancer on androgen deprivation therapy: a pilot and feasibility study.

Authors:  Natalia S Zabegalina; Michaël M E L Henderickx; Veerle Lamotte; Bart Segers; Gaetane Stassijns; Stefan De Wachter; Lucien Hoekx
Journal:  Cent European J Urol       Date:  2018-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.